Long-term efficacy of immune checkpoint inhibitors with or without chemotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck: a commentary on the 4-year follow-up of the KEYNOTE-048 trial
Transl Cancer Res. 2023 May 31;12(5):1363-1367.
doi: 10.21037/tcr-23-48.
Epub 2023 Apr 14.